Belgium – Antineoplastic and immunomodulating agents – Lénalidomide
Published on December 18, 2025
Tender Description
Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Lénalidomide » en gélules de 2,5mg, 5mg, 7,5mg, 10mg, 15mg, 20mg et 25mg et présentés en blister.
Unlock Full Tender Insight
Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.
It's free to get started. No credit card required.
